EDGAR Filing Documents for 0001564590-20-025132

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001564590-20-025132

Filing Date

2020-05-13

Accepted

2020-05-13 17:15:27

Documents

Period of Report

2020-05-13

Document Format Files

Seq	Description	Document	Type	Size
1	6K	lmnl-6k_20200513.htm	6-K	24501
2	EX-99.1	lmnl-ex991_6.htm	EX-99.1	40743
3	EX-99.2	lmnl-ex992_10.htm	EX-99.2	922472
4	EX-99.3	lmnl-ex993_9.htm	EX-99.3	1799081
5	EX-99.4	lmnl-ex994_7.htm	EX-99.4	18561
6	EX-99.5	lmnl-ex995_8.htm	EX-99.5	19199
7	GRAPHIC	guzvilltqpks000001.jpg	GRAPHIC	12047
8	GRAPHIC	ggkilmefymew000001.jpg	GRAPHIC	4060
9	GRAPHIC	g2yllzbs4njv000001.jpg	GRAPHIC	38195
	Complete submission text file	0001564590-20-025132.txt		2900897

Mailing Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4

Business Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4 514-341-2115

Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)